Medical Innovation Exchange

ESMO: GSK keeps the faith in anti-TIGIT plans; it's 'not always about being first'

https://www.fiercebiotech.com/biotech/gsk-forging-ahead-2b-anti-tigit-plans-says-its-not-always-about-being-first

Leave a Comment

Your email address will not be published.

Leave the field below empty!